🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for transformative discoveries that clarify how the immune system attacks dangerous pathogens while sparing the body's own cells.

Three esteemed researchers—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their work identified unique "security guards" within the immune system that remove malfunctioning immune cells capable of harming the body.

The discoveries are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will share a prize fund valued at 11 million Swedish kronor.

Decisive Findings

"The work has been essential for understanding how the immune system functions and the reason we do not all develop serious autoimmune diseases," commented the chair of the award panel.

This trio's studies address a fundamental mystery: How does the immune system protect us from countless infections while leaving our healthy cells intact?

Our immune system employs white blood cells that search for signs of infection, even viruses and germs it has not met before.

These defenders employ sensors—known as recognition units—that are generated randomly in a vast number of variations.

This gives the defense network the capacity to fight a broad range of threats, but the randomness of the process inevitably creates white blood cells that can target the host.

Protectors of the Body

Scientists earlier understood that a portion of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the system to disarm other immune cells that attack the body's own tissues.

It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These findings have laid the foundation for a novel area of investigation and spurred the creation of innovative treatments, for example for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on lowering their numbers.

In self-attack disorders, trials are testing increasing T-reg cells so the organism is no longer under attack. A comparable method could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of a Japanese institution, conducted tests on mice that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that introducing defense cells from other mice could stop the disease—implying there was a system for blocking defenders from harming the body.

Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and humans that led to the discovery of a gene vital for how regulatory T-cells function.

"Their pioneering research has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally targeting the body's own tissues," said a prominent physiology specialist.

"This research is a striking example of how basic physiological study can have far-reaching consequences for human health."